FDA OKs Tysabri to fight Crohn's disease
564004
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
16443
Biogen and Elan receive an additional approval for Tysabri.
392549
A molecule which may protect against food allergy has been identified.
566618
Patients with Crohn&#39;s disease, a chronic inflammatory bowel disease, who do not respond to conventional treatment, may get symptom relief by swallowing parasite eggs.
384223
The US Food and Drug Administration has approved the first over-the-counter diet drug, a lower dose version of a prescription drug made by British firm GlaxoSmithKline.
649663
LOS ANGELES/NEW YORK  - The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc.'s   drug Vectibix for use in colon cancer patients whose tumors   have spread despite chemotherapy treatment.
135618
(National-NBC) Nov. 24, 2004 - The Food and Drug Administration has approved the first drug that specifically targets Multiple Sclerosis.
64590
WASHINGTON -- For patients suffering from a severe form of Crohn's disease, a remedy already on the shelf to treat other maladies and a brand-new drug could offer new hope.
654060
The US Food and Drug Administration will allow olive oil to carry a label claming it may reduce the risk of coronary heart disease.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.
251574
U.S. health regulators have approved GlaxoSmithKline Plc's   pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.
714089
U.S. regulators approved the first  generic rival to Johnson & Johnson's Duragesic pain relief skin  patch, the U.S. Food and Drug Administration said on Friday.
289071
Today was a day of good news for multiple sclerosis patients: FDA granted approval to a new anti-multiple sclerosis drug Antegren developed by Biogen Idec Inc.
470175
Pharmaceuticals Corporation today announced that the US Food and Drug Administration (FDA) has approved EnablexÂ® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
79616
AstraZeneca Plc, the UK&#39;s second largest drugmaker, said US regulators approved its ulcer treatment Nexium for use in reducing the risk of stomach ulcers in patients taking certain painkillers